Fauman B, Aldinger G, Fauman M, Rosen P
Clin Toxicol. 1976;9(4):529-38. doi: 10.3109/15563657608988154.
Phencyclidine use has been noted to produce a psychosis of several week's duration in a small fraction of users. Descriptions of the premorbid personalities of those who became psychotic resemble descriptions of LSD and marijuana users who experienced prolonged psychiatric difficulty. In addition, the psychosis produced can often be recognized as a "hallucinogen" psychosis. Certain features of the phencyclidine psychosis, namely the neurologic abnormalities, dose-related severity of symptoms, and regularity of the length of illness, are not noted with other psychedelic drugs, leading to the conclusion that PCP psychosis is a drug effect rather than a brief functional psychosis precipitated by the disintegrating PCP experience. However, the infrequent occurrence of psychosis in the (apparently) large exposed population still suggests that this is a combination of drug effect and vulnerable, pathologic personality.
已注意到,在一小部分使用者中,使用苯环利定会产生持续数周的精神病症状。那些出现精神病症状的使用者病前人格描述,与经历长期精神问题的麦角酸二乙酰胺(LSD)和大麻使用者的描述相似。此外,所产生的精神病症状通常可被认定为“致幻剂”精神病。苯环利定精神病的某些特征,即神经学异常、与剂量相关的症状严重程度以及病程长短的规律性,在其他迷幻药物中并未出现,由此得出结论,苯环己哌啶(PCP)精神病是一种药物效应,而非因PCP体验瓦解引发的短暂功能性精神病。然而,在(显然)大量接触该药物的人群中,精神病症状的发生频率较低,这仍表明这是药物效应与易患精神病的病理人格相结合的结果。